GENUS FDA Wednesday, April 22, 2020 0.00 Neutral

FDA Approves Unknown Drug — GENUS

FDA has granted approval to GENUS for generic medication associated with ANDA207108, marking a continuation of the company's push into specified therapeutic markets. This approval is expected to bolster GENUS's revenue streams and maintain its competitive positioning within the generic sector without the need for additional generic ingredients.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day